Feb 12, 2025

OICR welcomes Dr. David Cescon as Scientific Director, Clinical Translation

Jan 15, 2025

Let’s talk about clinical trials: How patients are protected

Oct 03, 2024

Groundbreaking radiotherapy research changes how metastatic cancers are treated

Jun 18, 2024

Landmark trial brings genomic testing to thousands of Ontarians with cancer

May 27, 2024

New 3CTN initiative aims to address barriers faced by underrepresented populations and expand clinical trial involvement

Feb 27, 2024

Using AI to connect cancer patients with cutting-edge clinical trials

Aug 11, 2023

The secret to stopping deadly cancer recurrences may be in your blood

Jul 25, 2023

OICR introduces groundbreaking test proven to find traces of cancer in blood

Jul 07, 2023

Fecal transplants bolster melanoma treatment in unique clinical trial

Nov 24, 2022

Navigating hope: Helping cancer patients find and enrol in clinical trials

Nov 17, 2022

How patients can improve the way new cancer therapies are assessed

Oct 05, 2022

Patient perspectives fuelling translational OICR studies

Aug 24, 2022

Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging

Aug 15, 2022

Trusting the gut in cancer research: Q&A with Dr. Saman Maleki

Jun 16, 2022

OICR announces funding for three new window-of-opportunity clinical trials

May 10, 2022

New research asks if clinical trials are losing sight of what matters most to cancer patients

Dec 15, 2021

Mapping the Canadian clinical trials landscape in precision oncology to identify trial opportunities for patients, clinicians and researchers

Jun 09, 2021

New OICR Investigator aims to improve cancer treatment in Ontario and worldwide

May 06, 2021

Canadian Remote Access Framework for Clinical Trials brings new opportunities for cancer patients residing in rural and remote communities

Feb 04, 2021

Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard

Jul 27, 2020

Evolving treatment to evolving tumours: How OICR-supported researchers are getting ahead of ovarian cancer

Sep 11, 2019

Using the “window of opportunity” to understand biomarkers and tumour biology

May 17, 2019

What could we do if we had a clearer picture of prostate cancer?

Jan 29, 2019

First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment

Dec 14, 2018

Pan-Canadian radiotherapy group advancing care by reducing barriers to conducting clinical trials

Jul 11, 2018

New funding for the Canadian Cancer Clinical Trials Network will help more cancer patients access clinical trials

Jun 14, 2018

New OICR President and Scientific Director comments on breakthrough in breast cancer T-cell immunotherapy

Mar 06, 2018

Canadian pancreatic cancer research team provides personalized medicine, new hope to patients

Jan 30, 2018

Early results from COMPASS trial demonstrate benefits of using genomic sequencing to guide treatment for pancreatic cancer

Sep 06, 2017

Innovative study brings next-generation genomic sequencing to more Ontario cancer patients

May 03, 2017

Study bringing more precision medicine to Ontario’s cancer patients

Apr 26, 2017

Clinical trial opens for promising combination therapy

Nov 02, 2016

FACIT start-up Turnstone Biologics closes USD $41M financing

Oct 21, 2016

OICR-led study finds four unique genomic signatures in pancreas cancer, uncovers potential of immunotherapies

Jun 21, 2016

Ask an expert: How are new cancer drugs created?

Jun 01, 2016

Making prostate cancer diagnosis more PRECISE

Jun 01, 2016

Clinical trial launched to test use of MRI to improve prostate cancer diagnosis and management

May 20, 2016

The little-known connection between citrus fruit and the first clinical trial

May 19, 2016

Ask an expert: All about clinical trials

May 04, 2016

It’s time to start talking about clinical trials

May 04, 2016

The Canadian Cancer Clinical Trials Network launches Ask Me Campaign to raise awareness of cancer clinical trials

Jan 09, 2016

3CTN-funded clinical trial to test new method of finding genomic changes in patients with aggressive prostate cancer

Jan 05, 2016

OICR funds world-first clinical trial using cancer-fighting viruses

Oct 28, 2015

FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management

Jul 10, 2015

Cancer patients treated in world-first clinical trial of Canadian viral therapy

Feb 25, 2015

OICR extends collaboration with Janssen Inc. to develop clinical trials for prostate cancer

Jan 13, 2015

Canadian Cancer Clinical Trials Network receives new funding, launches online service to connect patients to clinical trials